Ambry Genetics Corp:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Ambry Genetics Corp - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10299
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:33
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Ambry Genetics Corp (Ambry Genetics), a subsidiary of Konica Minolta Inc, is a provider of clinical genetic testing services. The company provides genetic diagnosis for various conditions including hereditary cancer, epilepsy, hereditary cardiovascular disease and neurodevelopmental disorders among others. It offers bioinformatics solutions for transcriptomic, genomic, and epigenomic data analysis. Ambry Genetics specializes in providing whole transcriptome and targeted RNA analysis, tumor genomic profiling, immuno-oncology biomarker analysis, and ctDNA analysis. It also offers contract research services to the biotech and pharmaceutical industries. The company caters to academic institutions, researchers, healthcare professionals, and hospitals. Ambry Genetics is headquartered in Aliso Viejo, California, the US.

Ambry Genetics Corp – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Ambry Genetics Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Ambry Genetics Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Ambry Genetics Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Ambry Genetics Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Ambry Genetics Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Ambry Genetics Corp, Medical Equipment, Deal Details 10
Partnerships 10
Ambry Genetics Partners with Beth Israel Deaconess Medical Center, University of Pittsburgh and HonorHealth Research Institute 10
Acquisition 11
Konica Minolta Acquires Ambry Genetics 11
Ambry Genetics Acquires Progeny Software 13
Ambry Genetics Corp – Key Competitors 14
Ambry Genetics Corp – Key Employees 15
Ambry Genetics Corp – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Corporate Communications 17
Aug 21, 2018: Konica Minolta Precision Medicine appoints Dr. John E. Niederhuber as scientific advisory board chairman 17
Government and Public Interest 18
Apr 18, 2017: Ambry Genetics Recruits Patient Cohorts to Discover New Links between Genes and Autism 18
Product News 19
Dec 05, 2017: Ambry Presents Research Expanding Our Understanding of Gene Disease Relationships at the San Antonio Breast Cancer Symposium 19
Nov 28, 2017: Ambry Genetics’ Mitochondrial Disease Research May Help Develop Treatments Sooner 20
Oct 16, 2017: Ambry Presents Scientific Discovery to Enhance Clinical Practice at American Society for Human Genetics Annual Meeting 21
Sep 12, 2017: Ambry Announces New Research Grant Program in their Commitment Towards Advancing Science and Research at NSGC 2017 22
Jun 06, 2017: Ambry Launches Innovative Tumor/Germline Testing to Help Clinicians Guide Patient Treatment 23
Jun 02, 2017: Ambry to Present New Data Showing That up to 30% of Cancer Risk Carriers Are Missed by Current Testing Guidelines at the 2017 ASCO Meeting 25
Mar 20, 2017: Ambry Genetics Celebrates Translational Research at ACMG 2017 Presents 13 Abstracts and Plans to Launch a Personalized Genomic Test 27
Other Significant Developments 28
Jun 12, 2018: Akcea and Ambry Genetics to Launch hATTR Compass, a Genetic Testing Program for People with Suspected Hereditary ATTR Amyloidosis 28
Jan 31, 2018: Ambry Genetics and Invicro Announce Partnership to Provide Enhanced Capabilities with Advanced Genomics Services to Enable Precision Medicine 29
Sep 14, 2017: FDNA Teams with World’s Top Genetic Labs to Advance Genetic Testing for Rare Diseases 30
Sep 14, 2017: Ambry Genetics Announces Integration with FDNA to Advance Precision Medicine 31
Sep 12, 2017: Ambry Genetics & NorthShore University HealthSystem Partner to Accelerate Precision Medicine in Preventive Care 32
Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33

List of Tables
Ambry Genetics Corp, Medical Equipment, Key Facts 2
Ambry Genetics Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Ambry Genetics Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Ambry Genetics Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Ambry Genetics Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Ambry Genetics Corp, Deals By Market, 2012 to YTD 2018 8
Ambry Genetics Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Ambry Genetics Partners with Beth Israel Deaconess Medical Center, University of Pittsburgh and HonorHealth Research Institute 10
Konica Minolta Acquires Ambry Genetics 11
Ambry Genetics Acquires Progeny Software 13
Ambry Genetics Corp, Key Competitors 14
Ambry Genetics Corp, Key Employees 15
Ambry Genetics Corp, Subsidiaries 16

List of Figures
Ambry Genetics Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Ambry Genetics Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Ambry Genetics Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Ambry Genetics Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Ambry Genetics Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Ambry Genetics Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Ambry Genetics Corp, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Ambry Genetics Corp:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Holland America Line Inc:企業の戦略的SWOT分析
    Holland America Line Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • The Boston Beer Company, Inc.:企業の戦略・SWOT・財務分析
    The Boston Beer Company, Inc. - Strategy, SWOT and Corporate Finance Report Summary The Boston Beer Company, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • BiondVax Pharmaceuticals Ltd (BVXV):企業の財務・戦略的SWOT分析
    Summary BiondVax Pharmaceuticals Ltd (BiondVax Pharmaceuticals) is a biopharmaceutical company that develops universal flu vaccine. The company provides lead product M-001 is a synthetic peptide-based protein that offers protection against human influenza virus strains including seasonal influenza s …
  • Clean TeQ Holdings Ltd (CLQ):企業の財務・戦略的SWOT分析
    Summary Clean TeQ Holdings Ltd (Clean TeQ) is a clean technology company that offers air pollution control solutions using biotechnology-based processes. The company provides water treatment products such as advanced separations, advanced oxidation, encapsulated bacteria, continuous ionic filtration …
  • Evonik Industries AG:企業の戦略・SWOT・財務情報
    Evonik Industries AG - Strategy, SWOT and Corporate Finance Report Summary Evonik Industries AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Kumagai Gumi Co., Ltd.:企業の戦略・SWOT・財務分析
    Kumagai Gumi Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Kumagai Gumi Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Pennant International Group plc (PEN):企業の財務・戦略的SWOT分析
    Summary Pennant International Group plc (Pennant) is a technology company that offers information services, training systems, and software services to its customers. The company offers supportability engineering software products, generic training equipment and LSAR software. Pennant generic trainin …
  • Align Technology, Inc.:戦略・SWOT・企業財務分析
    Align Technology, Inc. - Strategy, SWOT and Corporate Finance Report Summary Align Technology, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • New Zealand Pharmaceuticals Ltd:企業の戦略的SWOT分析
    New Zealand Pharmaceuticals Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Lennox International Inc.:企業の戦略・SWOT・財務情報
    Lennox International Inc. - Strategy, SWOT and Corporate Finance Report Summary Lennox International Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Richter Gedeon Nyrt (RICHTER):製薬・医療:M&Aディール及び事業提携情報
    Summary Richter Gedeon Nyrt (Richter) is a pharmaceutical company that develops, manufactures and commercializes a wide range of drugs including original, generic and licensed products and over-the-counter (OTC) medicines. The company’s product portfolio encompasses medicines to treat gynaecological …
  • Eddie Stobart Logistics Plc:企業の戦略・SWOT・財務分析
    Eddie Stobart Logistics Plc - Strategy, SWOT and Corporate Finance Report Summary Eddie Stobart Logistics Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Billabong International Limited:企業の戦略的SWOT分析
    Billabong International Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Intellect Design Arena Limited:戦略・SWOT・企業財務分析
    Intellect Design Arena Limited - Strategy, SWOT and Corporate Finance Report Summary Intellect Design Arena Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Diageo plc:企業の戦略・SWOT・財務情報
    Diageo plc - Strategy, SWOT and Corporate Finance Report Summary Diageo plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • BioRap Technologies Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary BioRap Technologies Ltd (BioRap) is a technology transfer company that offers biomedical solutions for contemporary health care industry. The company’s technologies are used in the treatment of macular disease, alopecia, cardiovascular disease, cancer and autoimmune diseases, cancer therapy, …
  • Intercede Group plc (IGP):企業の財務・戦略的SWOT分析
    Intercede Group plc (IGP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Anadolu Anonim Turk Sigorta Sirketi:企業の戦略・SWOT・財務情報
    Anadolu Anonim Turk Sigorta Sirketi - Strategy, SWOT and Corporate Finance Report Summary Anadolu Anonim Turk Sigorta Sirketi - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Genetic Technologies Ltd (GTG)-医療機器分野:企業M&A・提携分析
    Summary Genetic Technologies Ltd (GTG) is a genetic tests company that offers testing products and services to assess sporadic breast cancer risk and cancer development, progression and management. It delivers the offerings by BREVAGen and BREVAGenplus tests. BREVAGen test enables the customers to a …
  • United Community Banks Inc:企業のM&A・事業提携・投資動向
    United Community Banks Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's United Community Banks Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆